UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000053605
Receipt number R000061143
Scientific Title A study to evaluate safety and mechanisms through food intake using existing specimens.
Date of disclosure of the study information 2024/04/15
Last modified on 2024/02/13 12:17:05

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A study to evaluate safety and mechanisms through food intake using existing specimens.

Acronym

A study to evaluate safety and mechanisms through food intake using existing specimens.

Scientific Title

A study to evaluate safety and mechanisms through food intake using existing specimens.

Scientific Title:Acronym

A study to evaluate safety and mechanisms through food intake using existing specimens.

Region

Japan


Condition

Condition

Healthy adults

Classification by specialty

Not applicable Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

A study to evaluate safety and mechanisms through food intake using existing specimens.

Basic objectives2

Safety

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

blood level of TMAO
related metabolites (betaine, L-alpha-Glycerylphosphorylcholine, folic acid)

Key secondary outcomes



Base

Study type

Others,meta-analysis etc


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

60 years-old <=

Age-upper limit

80 years-old >

Gender

Male and Female

Key inclusion criteria

Subjects examined in the other study (UMIN000041554)

Key exclusion criteria

Subjects whose specimen have not been obtained in the study (UMIN000041554).

Target sample size



Research contact person

Name of lead principal investigator

1st name Yumi
Middle name
Last name Takeda

Organization

Kewpie Corporation

Division name

R&D Division

Zip code

1820002

Address

2-5-7, Sengawa-cho, Chofu-shi, Tokyo

TEL

03-5384-7759

Email

yumi_takeda@kewpie.co.jp


Public contact

Name of contact person

1st name Yui/ Wei
Middle name
Last name Ou/Wang

Organization

Kewpie Corporation

Division name

R&D Division

Zip code

1820002

Address

2-5-7, Sengawa-cho, Chofu-shi, Tokyo

TEL

03-5384-7759

Homepage URL


Email

yui_ou@kewpie.co.jp


Sponsor or person

Institute

Kewpie Corporation

Institute

Department

Personal name



Funding Source

Organization

Kewpie Corporation

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethical Committee of Kobuna Orthopedics Clinic

Address

5-656-17, Jotomachi, Maebashi Shi, Gumma Ken, 371-0016, Japan

Tel

027-212-5608

Email

sagawa@mc-connect.co.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

株式会社LSIメディエンス LSI Medience
広島大学 Hiroshima University


Other administrative information

Date of disclosure of the study information

2024 Year 04 Month 15 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2024 Year 02 Month 02 Day

Date of IRB

2024 Year 02 Month 08 Day

Anticipated trial start date

2024 Year 04 Month 15 Day

Last follow-up date

2024 Year 11 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

This study is conducted using samples obtained in the other study (UMIN000041554). There is no intervention and invasion in this study.


Management information

Registered date

2024 Year 02 Month 13 Day

Last modified on

2024 Year 02 Month 13 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000061143


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name